Harnessing the Power of Generative AI and Language Models for Next-Gen Life Sciences
ABSTRACT
Dive into the transformative realm of Life Sciences as we explore the latest advancements and future directions powered by Generative AI and Large Language Models (LLMs). This insightful talk provides a comprehensive overview of the industry's current landscape, spotlighting groundbreaking AI-powered solutions reshaping research and development. Join us as we unlock the full potential of AI to foster innovation and propel the life sciences into a new era of discovery and efficiency.
BIOGRAPHY
Ashwini Ghogare is a leader in transformational drug discovery technologies with extensive experience in software development, new business incubation, and software product sales. She currently heads the AI and Automation for Drug Discovery in MilliporeSigma, which is responsible for setting up the AI-powered drug discovery and automation portfolio as an intrapreneurial venture across Life Sciences & Healthcare. Previously, Ashwini led strategic initiatives to identify transformative AI technologies for drug discovery applications. She successfully built and launched a new AI-powered drug design solution, AIDDISON™. Additionally, she was responsible for the global services and commercial licensing of Synthia™, MilliporeSigma’s flagship retrosynthesis software product. Ashwini holds a Ph.D. in organic chemistry in photobiology, focusing on the photochemical drug delivery system. Her research led to the creation of a start-up, SingletO2 Therapeutics LLC.